Estrace (Estradiol Vaginal) - Adverse Event Reports - Hospitalization - Fibrocystic Breast Disease

Adverse event in 62 year old female receiving Estrace (Estradiol Vaginal)

Reported by a individual with unspecified qualification from United States on 2007-07-02

Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)

Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Start date: 1989-01-01

Premarin
    Dosage: 0.625 unk, unk
    Administration route: Oral
    Start date: 1989-01-01

Prempro
    Indication: Menopause
    Start date: 1999-04-01
    End date: 2002-04-01

Provera
    Dosage: 10 mg, unk
    Start date: 1989-01-01

Estratest
    Start date: 1990-01-01
    End date: 1999-01-01

Cycrin
    Start date: 1999-01-01

Estrace
    Dosage: unk, qhs
    Start date: 1999-01-01

Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem

Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)

Reported by a individual with unspecified qualification from United States on 2007-03-27

Patient: 59 year old female, weighing 96.1 kg (211.5 pounds)

Adverse reactions / side effects: Abdominal Pain, Abdominal Operation, Urinary Incontinence, Cervix Disorder, Incisional Hernia, Upper Respiratory Tract Infection, Central Venous Catheterisation, Postmenopausal Haemorrhage, Colostomy, Tendonitis, Rectal Prolapse, Breast Cancer, Enterostomy, Pelvic Abscess, Bursitis, non-Cardiac Chest Pain, Menopause, Cholelithiasis, Emotional Distress, Diverticulum, Vaginal Infection, Uterine Haemorrhage, Oophorectomy, Bladder Prolapse, Post Procedural Complication, Pain, Pelvic Pain, Cardiac Valve Disease, Hypercholesterolaemia, Ovarian Cystectomy, Fibrocystic Breast Disease, Basal Cell Carcinoma, Haemorrhagic Ovarian Cyst, Injury, Renal Failure Acute, Cataract, Mass, Urinary Tract Infection, Synovitis, Hernia, Tubal Ligation, Osteoarthritis, Adhesiolysis, Small Intestinal Resection, Radical Mastectomy, Uterine Prolapse Repair, Hypertension, Leukopenia, Abdominal Adhesions

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.1 mg, unk
    Start date: 1999-08-02

Loestrin 1.5 / 30
    Dosage: 1.5 mg, unk
    Start date: 1994-09-08

Prempro
    Dosage: .625/5 mg
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1997-06-25
    End date: 2001-12-02

Premarin
    Dosage: 0.625 mg, qd
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1984-09-26
    End date: 1997-10-01

Provera
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1994-05-23

Provera
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 1996-01-02
    End date: 1997-10-01

Estrace
    Dosage: 1 mg, qd
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-05-23

Estrace Vaginal Cream
    Dosage: 2 g oncde per week
    Indication: Menopausal Symptoms
    Start date: 1994-04-27

Estrace Vaginal Cream
    Dosage: 2 g once per week
    Start date: 1994-05-23

Other drugs received by patient: Prilosec; Avalide

Adverse event in 58 year old female receiving Estrace (Estradiol Vaginal)

Reported by a physician from United States on 2007-03-15

Patient: 58 year old female

Adverse reactions / side effects: Pulmonary Hypertension, Biopsy Breast Abnormal, Diabetes Mellitus, Dilatation Ventricular, Tricuspid Valve Incompetence, Treatment Noncompliance, Surgery, Atrial Hypertrophy, Oedema Peripheral, Breast Hyperplasia, Echocardiogram, Back Pain, Supraventricular Tachycardia, Breast Cancer Female, Cholelithiasis, Ventricular Dysfunction, Cholecystectomy, Homicidal Ideation, Scan Myocardial Perfusion Abnormal, Head Injury, Breast Cancer Stage IV, Pain, Hemiparesis, Fall, Fatigue, Fibrocystic Breast Disease, Coronary Artery Bypass, Dizziness, Lymphoedema, Atrial Flutter, Urinary Tract Infection, Atrial Fibrillation, Cerebrovascular Accident, Cardiac Pacemaker Insertion, Arthralgia, Mitral Valve Incompetence, Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Vivelle
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Premarin
    Dosage: 10 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Provera
    Dosage: 0.625 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Curretab
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estrace
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

MPA
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Prempro
    Dosage: 0.625/25 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1996-08-01
    End date: 2002-08-01